Prepubertal onset of diabetes prevents expression of renal cortical connective tissue growth factor

Pediatric Nephrology

Volumn 23, Issue 2, 2008, Pages 275-283

  Langer, William J ^a   Devish, Kay ^a   Carmines, Pamela K ^b   Lane, Pascale H ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Follistatin; Microarray studies; Myc; Puberty; Transforming growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FOLLISTATIN; MESSENGER RNA; MYC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN MYELOBLASTOSIS VIRUS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GENETIC REGULATION; JUVENILE DIABETES MELLITUS; KIDNEY CORTEX; MALE; MATURITY ONSET DIABETES MELLITUS; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE; ONSET AGE; PREPUBERTY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AGING; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLISTATIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, MYB; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY CORTEX; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEXUAL MATURATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 38349036123     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0642-8     Document Type: Article

References (56)

1. Lane P (2002) Diabetic kidney disease: Impact of puberty. Am J Physiol Renal Physiol 283:F589-F600
2. American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care 27 [Suppl 1]:S79-S83
3. American Diabetes Association (2006) Standard of medical care in diabetes. Diabetes Care 29 [Suppl 1]:S15-S35
4. Bach L, Cooper M, Vranes D, Allen T, Rumble J, Jerums G (1994) Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat. Diabetes Res 27:27-38
5. Bach L, Cox A, Jerums G (1991) Diabetes-related renal growth and IGF-I accumulation in castrated rats. Diabetes Res Clin Pract 14:15-20
6. Bach LA, Jerums G (1990) Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 39:557-562
7. Ellis EN, Wiegmann TB, Savin VJ (1992) Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat. Diabetes 41:1106-1112
8. Lane P, Snelling D, Hollman A, Langer W (2001) Puberty permits increased expression of renal transforming growth factor-b1 in experimental diabetes. Pediatr Nephrol 16:1033-1039
9. Lane PH (1997) Age of onset of streptozocin diabetes determines the renal structural response in the rat. Pediatr Res 41:912-915
10. Drummond K, Mauer SM; International Diabetic Nephropathy Study Group (2002) The early natural history of nephropathy in type 1 diabetes. II. Early renal structural changes in type 1 diabetes. Diabetes 51:1580-1587
11. Ellis EN, Warady BA, Wood EG, Hassanein R, Richardson WP, Lane PH, Howard C, Kemp SF, Aceto T, Garibaldi L, Wiegmann TB, Savin VJ (1997) Renal structural-functional relationships in early diabetes mellitus. Pediatr Nephrol 11:584-591
12. Mauer SM, Drummond K; International Diabetic Nephropathy Study Group (2002) The early natural history of nephropathy in type 1 diabetes. I. Study design and baseline characteristics of the study participants. Diabetes 51:1572-1579
13. Østerby R, Gundersen H (1975) Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 11:225-229
14. Rudberg S, Osterby R (1998) Diabetic glomerulopathy in young IDDM patients. Horm Res 50 [Suppl 1]:17-22
15. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M; International Diabetic Nephropathy Study Group (2005) The early natural history of nephropathy in type 1 diabetes. III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54:2164-2171
16. Donaghue K, Fairchild J, Chan A, Hing S, King J, Howard N, Silink M (1997) Diabetes microvascular complications in prepubertal children. J Pediatr Endocrinol Metab 10:579-585
17. Rudberg S, Dahlquist G (1996) Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care 19:369-371
18. Rudberg S, Ullman E, Dahlquist G (1993) Relationship between early metabolic control and the development of microalbuminuria - a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:1309-1314
19. Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB, Oxford Regional Prospective Study Group (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care 22:495-502
20. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F (2003) Epidemiology of chronic renal failure in children: Data from the ItalKid Project. Pediatrics 111:e382-e387
21. Drozdz D, Drozdz M, Gretz N, Mohring K, Mehls O, Scharer K (1998) Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol 12:630-636
22. Konda R, Sakai K, Ota S, Takeda A, Orikasa S (1997) Followup study of renal function in children with reflux nephropathy after resolution of vesicoureteral reflux. J Urol 157:975-979
23. Lal R, Bhatnagar V, Mitra D (1999) Long-term prognosis of renal function in boys treated for posterior urethral valves. Eur J Pediatr Surg 9:307-311
24. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau W-C, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, Edgar R (2005) NCBI GEO: Mining millions of expressions profiles - database and tools. Nucleic Acids Res 33:D562-D566
25. Lane P, Sun J, Devish K, Langer W (2004) Dissociation of renal TGF-β and hypertrophy in female rats with diabetes mellitus. Am J Physiol Renal Physiol 287:F1011-F1020
26. Lane P, Snelling D, Langer W (2001) Streptozocin diabetes elevates all isoforms of TGF-β in the rat kidney. Int J Exp Diabetes Res 2:55-62
27. Chen S, Jim B, Ziyadeh FN (2003) Diabetic nephropathy and transforming growth factor-b: Transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23:532-543
28. McLennan S, Wang X, Moreno V, Yue D, Twigg S (2004) Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinol 145:5646-5655
29. Zhou G, Li C, Cai L (2004) Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor β-independent pathway. Am J Pathol 165:2033-2043
30. GenomeNet (26 April 2006) Kyoto Encyclopedia of Genes and Genomes (KEGG) [Online Database]. Kyoto University Bioinformatics Center. http://www.genome.jp/kegg/regulation/html
31. Piek E, Heldin C-H, Ten Dijke P (1999) Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13:2105-2124
32. Leask A, Abraham DJ (2003) The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81:355-363
33. Leask A, Holmes A, Black CM, Abraham DJ (2003) Connective tissue growth factor gene regulation. J Biol Chem 278:13008-13015
34. Leask A, Abraham DJ (2004) TGF-β signaling and the fibrotic response. FASEB J 18:816-827
35. Leask A, Abraham DJ (2006) All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810
36. Fine LG, Bandyopadhay D, Normal JT (2000) Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 57 [Suppl 75]:S22-S26
37. Tanaka T, Kato H, Kojima I, Ohse T, Son D, Tawakami T, Yatagawa T, Inagi R, Fujita T, Nangaku M (2006) Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci 61:795-805
38. Michel U, Farnworth P, Findlay J (1993) Follistatins: More than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 91:1-11
39. Hashimoto O, Nawasaki N, Tsuchida K, Shimasaki S, Hayakawa T, Sugino H (2000) Difference between follistatin isoforms in the inhibition of activin signalling. Activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin. Cell Signal 12:565-571
40. Iemura S-I, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N (1998) Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95:9337-9342
41. DePaolo LV (1997) Inhibins, activins, and follistatins: The saga continues. Proc Soc Exp Biol Med 214:328-339
42. Mather JP, Moore A, Li R-H (1997) Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med 215:209-222
43. Renier M, Vereecken A, Buytaert P (1998) Inhibins, activins and follistatins: A review of complex regulators of the reproductive system. Eur J Contracept Reprod Health Care 3:129-135
44. de Kretser D, Hedger M, Phillips D (1999) Activin A and follistatin: their role in the acute phase reaction and inflammation. J Endocrinol 161:195-198
45. Phillips DJ, Jones KL, Scheerlinck J-PY, Hedger MP, de Krester DM (2001) Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol Cell Endocrinol 180:155-162
46. Jones KL, de Kretser DM, Patella S, Phillips DJ (2004) Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 225:119-125
47. Shimasaki S, Koga M, Buscaglia M, Simmons D, Bicsak T, Ling N (1989) Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol 3:651-659
48. Michel U, Findlay J (1990) Rat follistatin: Gonadal and extragonadal expression and evidence for alternative splicing. Biochem Biophys Res Comm 173:401-407
49. Kogawa K, Ogawa K, Hayashi Y, Nakamura T, Titani K, Sugino H (1991) Immunohistochemical localization of follistatin in rat tissues. Endocrinol Jpn 38:383-391
50. Michel U, Farnworth P (1992) Follistatin steady state messenger ribonucleic acid levels in confluent cultures of a rat renal mesangial cell line are regulated by multiple factors. Endocrinol 130:3684-3693
51. Michel U, Rao A, Findlay JK (1991) Rat follistatin: Ontogeny of steady-state mRNA levels in different tissues predicts organ-specific functions. Biochem Biophys Res Comm 180:223-230
52. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645
53. Lee CM, Reddy EP (1999) The v-myc oncogene. Oncogene 18:2997-3003
54. Gene Ontology Consortium (12 July 2006) Gene Ontology Database [Online Database]. Gene Ontology Consortium. http://www.geneontology.org/ GO.slims.shtml
55. Han DC, Isono M, Hoffman BB, Ziyadeh FN (1999) High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-β. J Am Soc Nephrol 10:1891-1899
56. Shankland S, Scholey JW (1995) Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 47:782-788